Introduction {#sec1-1}
============

Hemophilia A (HA) is a common inherited recessive X-linked disorder of blood clotting caused by deficiency of factor VIII in the coagulation cascade and affects approximately 1 in 5,000 males world-wide.\[[@CIT1][@CIT2]\] The FVIII gene, comprises 26 exons ranging from 69 bp (exon 5) to 3.1 kb (exon 14) in size, spans 186 kb of genomic DNA and produces a 9030 nt mRNA. According to the UK Hemophilia Centre Doctors\' Organisation (UKHCDO) Hemophilia Genetics Laboratory Network, the severity of HA in the pedigree should be determined first as this will influence the diagnostic strategy to be employed. Severe Hemophiliacs should be screened for the intron 22 inversion mutation followed by the intron 1 inversion mutation. This approach identifies the underlying mutation in 45-50% of severe HA patients.\[[@CIT3][@CIT4]\] The remaining severe HA pedigrees should then be analyzed further either by full mutation or linkage analysis. Mutations have been found in nearly all 26 exons of the factor VIII gene, over 400 mutations have been identified\[[@CIT5][@CIT6]\] and de novo mutations represent approximately 30% of all cases.\[[@CIT7]\] The most common detection methods include DNA sequence analysis which requires numerous reactions and individual analysis of each exon or alternative screening methods such as single-stranded conformation polymorphism (SSCP),\[[@CIT8]\] denaturing gradient gel electrophoresis (DGGE)\[[@CIT8]\] and denaturing high performance liquid chromatography (dHPLC).\[[@CIT9]\] We applied the new combinatorial sequencing-by-hybridization (cSBH) as an alternative method to the traditional Sanger dideoxy chain termination approach.\[[@CIT10][@CIT11]\] Previous works have shown that cSBH is an efficient rapid and alternative method for mutation detection.\[[@CIT12][@CIT13]\]

We increased the quality of results with a new cSBH method that use two different colors (TAMRA and QUASAR). The platform is an indirect method which uses standard chemistry of base-specific hybridization of complementary nucleic acids to indirectly assemble the order of bases in a target DNA. Short oligonucleotide probes are arrayed in the form of high-density arrays of universal sequence and hybridized to sample DNA molecules. The resulting hybridization pattern is used to generate the target sequence using computer algorithms.

We report development of a strategy to implement 2-color cSBH to screen a range of mutations within the FVIII gene.

Materials and Methods {#sec1-2}
=====================

Sample {#sec2-1}
------

After approval of the local ethics committee, the study was carried out according to the Principles of the Declaration of Helsinki. After informed consent the genomic DNA was isolated from clinically diagnosed individuals with HA, regularly investigated for the detection of the causative mutation within the F8 gene. Samples were labelled using an internal lab code. We selected samples that presented a point mutation at different position in the F8 gene. We selected samples 1 and 20, which present a nonsense mutation; samples 73 and 95, which present a 2 bp deletion; samples 2, 6, 37, and 89, which present a single bp deletion; and a series of randomly selected samples in which a missense mutation was identified. Samples 1 and 20 and 2, 6, and 37 carry the same mutation and were used to verify the quality of results in the analysis. In addition, we randomly selected 7 HA male patients, who were previously excluded to carry the inversion of the intron 1 or of the intron 22 and in whom no gene mutation was detected by a first FVIII gene screening, using common strategies (SSCP, DGGE, or dHPLC). All the patients involved in this study are regularly followed at one of 50 hemophilia treatment centers spread all over the country and belonged to the Italian Association of Hemophilia Centers (AICE; *URL: <http://www.aiceonline.it>*), an organization which was founded with the aim to organize clinical and experimental national activities in inherited bleeding disorders. Patients were considered to have HA according to the international consensus of the 2001 International Society on Thrombosis and Haemostasis (ISTH) Factor VIII and Factor IX Subcommittee.\[[@CIT9]\] All known HA patients are registered and followed at one of these centers. For each patient clinical and laboratory data (including FVIII clotting activity and inhibitor) were recorded. DNA was extracted from 5 to 10 ml of EDTA treated peripheral blood leukocytes with in standard salting out method. Numbering of mutations and polymorphisms was in agreement with genomic DNA sequence in Hamsters database mutations (<http://europium.csc.mrc.ac.uk/WebPages/Main/main.htm>). Patient DNA was amplified for exons spanning the FVIII gene and encompassing each different disease-causing mutation.

Primer design {#sec2-2}
-------------

Primers for multiplex and nested PCR were obtained from MWG Deutschland, (HPLC purified) and designed using Primer 3 software ([www.genome.wi.mit.edu/cgibin/primer/primer3_www.cgi](http://www.genome.wi.mit.edu/cgibin/primer/primer3_www.cgi)) to span the entire HA gene coding regions with intron-exon boundary coverage.

DNA amplification {#sec2-3}
-----------------

The amplification of target for cSBH was performed in two consecutive steps \[[Table 1](#T0001){ref-type="table"}\]. The first required three different multiplex PCR reactions to amplify all exons while the second step, a nested-asymmetric PCR, generated single-stranded templates corresponding to sense and antisense strands. The multiplex PCR was performed in 25 µ l containing 100 ng of genomic DNA, 33 pmol of each primer suspended in three different mixes (Mix 1, 2, and 3 with primers for exons 1-9, 10-13 and 15-25, and 14 and 26, respectively). Reactions were performed for 40 cycles with an initial denaturation at 96°C for 15 min. The protocols to amplify Mix 1 required an initial denaturation at 96°C for 15 min, followed by 20 cycles of denaturation (96°C, 30 sec), annealing (52°C for 30 sec), and extension (72°C, 50 sec); while for Mix 2, 20 cycles of denaturation (96°C, 30 sec), annealing (55°C for 30 sec) and extension (72°C, 50 sec) with a final extension at 72°C for 7 min were required. In Mix 3 the annealing temperatures are 55°C and 58°C for exons 14 and 26, respectively. This separation is required to optimize the amplification conditions for all exons.

###### 

Sequence and position of primers used for multiplex and nested PCR reactions

  Exon      Multiplex PCR Sequence primers   Position[\*](#T000F1){ref-type="table-fn"}   Exon        Nested PCR Sequence primers   Position[\*](#T000F1){ref-type="table-fn"}   PCR Product
  --------- -------------------------------- -------------------------------------------- ----------- ----------------------------- -------------------------------------------- -------------
  Ex1_F     gttcttcctgtggctgcttc             -55/-35[°](#T000F2){ref-type="table-fn"}     Ex1_Fn      gctgcttcccactgataaaaa         -43/-22 [°](#T000F2){ref-type="table-fn"}    387 bp
  Ex1_R     agcagacttacatccccacaa            353-373                                      Ex1_Rn      ccgatcagaccctacaggac          325-344                                      
  Ex2_F     ttcaaatttgcctccttgct             23012-23032                                  Ex2_Fn      cagctgctttttgaagtgtcc         23068-23089                                  217 bp
  Ex2_R     tttggcagctgcacttttta             23328-23348                                  Ex2_Rn      cccaatttcataaatagcattcaa      23261-23284                                  
  Ex3_F     tttggaataacaggttttctgga          25562-25585                                  Ex3_Fn      ctttggcggacatctcattc          25602-25623                                  180 bp
  Ex3_R     gccaccattacaaagcacac             25808-25828                                  Ex3_Rn      tgacaggacaataggagggta         25661-25682                                  
  Ex4_F     cagtggatatagaaaggacaatttta       29534-29560                                  Ex4_F       cagtggatatagaaaggacaatttta    29534-29560                                  281 bp
  Ex4_R     ttcagttgtttgtacttctctgctt        29823-29848                                  Ex4_R       ttcagttgtttgtacttctctgctt     29823-29848                                  
  Ex5_F     ttgttcttactgtcaagtaactgatga      35313-35340                                  Ex5_Fn      ttgttcttactgtcaagtaactgatga   35313-35340                                  168 bp
  Ex5_R     tgatctttctataatcacctcctctt       35544-35570                                  Ex5_Rn      tgatctttctataatcacctcctctt    35544-35570                                  
  Ex6_F     gagcagggaaggagaaagg              37840-37859                                  Ex6_Fn      gcggtcattcatgagacaca          37863-37883                                  215 bp
  Ex6_R     ccgagctgtttgtgaactga             38101-38121                                  Ex6_Rn      ttggaagaccctgaggattg          38058-38078                                  
  Ex7_F     tttgtccattctgtcctagcaa           53089-53111                                  Ex7_Fn      tcatagccataggtgtcttattcc      53138-53162                                  350 bp
  Ex7_R     aatgtccccttcagcaacac             53481-53501                                  Ex7_Rn      gcaacacactatattcctgtacattg    53462-53488                                  
  Ex8_F     tagcctgcagaaacatgagc             55919-55939                                  Ex8_Fn      tgtttggtttgtctgactcca         56015-56036                                  322 bp
  Ex8_R     tggcttcaggatttgttggt             56365-56385                                  Ex8_Rn      tggggaagagagagtaccaat         56316-56337                                  
  Ex9_F     cactccttgccttgattgaa             56481-56501                                  Ex9_Fn      tttttcttcccaacctctcatc        56543-56565                                  260 bp
  Ex9_R     ccattggagacaaggctgaa             56833-56853                                  Ex9_Rn      tccagactttttcttcttacctga      56779-56803                                  
  Ex10_F    gaggccacttttatttatctgga          61462-61485                                  Ex10_Fn     gaccacagttttcttgttgatcc       61490-61511                                  192 bp
  Ex10_R    ggaccaacataattttagttgttattg      61711-61738                                  Ex10_Rn     aaaaagagctataaatcgagggaat     61656-61680                                  
  Ex 11_F   gaacccttgcaacaacaaca             65470-65490                                  Ex11_Fn     atggttttgcttgtgggtag          65533-65553                                  260 bp
  Ex11_R    ggggacatacactgagaatgaa           65808-65830                                  Ex11_Rn     agcacttggaaaggcaagaa          65783-65803                                  
  Ex12_F    tgctagctcctacctgacaaca           68617-68638                                  Ex12_Fn     gcatttctttacccctttcaa         68645-68666                                  230 bp
  Ex12_R    cattcattatctggacatcactttg        68890-68915                                  Ex12_Rn     ctttattcaccacccactgga         68854-68875                                  
  Ex13_F    tcatgacaatcacaatccaaaa           74746-74767                                  Ex13_Fn     cttttccccattgtttttgc          74795-74815                                  273 bp
  Ex13_R    gagcatacgaatggctagtgaa           75068-75083                                  Ex13_Rn     gcattcacagctgttggtaca         75047-75067                                  
                                                                                          Ex14-1_Fn   gagtcttattcttcctcatctcca      91023-91047                                  1022 bp
                                                                                          Ex14-1_Rn   gggccatcaatgtgagtctt          92025-92044                                  
  Ex14_F    ctgggaatgggagagaacct             90965-90985                                  Ex14-2_Fn   caaaacttccaataattcagcaa       91994-92017                                  1176 bp
  Ex14_R    ttgttggtgtcatcatctgg             94206-94226                                  Ex14-2_Rn   acctttgcaatgggtaatgg          93150-93170                                  
                                                                                          Ex14-3_Fn   cgagcaccctcacacagata          93037-93057                                  1156 bp
                                                                                          Ex14-3_Rn   cacaagagcagagcaaagga          94173-94193                                  
  Ex15_F    gcttggcaagagtatttcaagg           116010-116032                                Ex15_Fn     ggcacctaggaaaatgagga          116067-116087                                269 bp
  Ex15_R    aaaatttccaaaagtgggaataca         116371-116393                                Ex15_Rn     ttttcttgtaattccactgtcctt      116312-116336                                
  Ex16_F    aaagacaggtatttcttttagggatg       117604-117630                                Ex16_Fn     gatcctagaagattattcttgcttttt   117648-117676                                300 bp
  Ex16_R    ttgcacgtaggataaatatcaaaa         117981-118003                                Ex16_Rn     ccaaaaagtggtcagcacaa          117929-117949                                
  Ex17_F    tctggttcataggtgagagagc           118144-118166                                Ex17_Fn     gattgatgtcttccctcccta         118178-118199                                301 bp
  Ex17_R    ccctggatcaagtctcatttg            118484- 118505                               Ex17_Rn     agtgcaatctgcatttcacag         118458-118479                                
  Ex18_F    tggtggagtggagagaaagaa            118570-118591                                Ex18_Fn     ggcttctctgtgtccttctcc         118613-118634                                229 bp
  Ex18_R    gtgttcccagtgcctagacc             118880-118900                                Ex18_Rn     aaagagcacaaacaagctcatac       118819-118842                                
  Ex19_F    ttcgcataaaccaatgtatctca          120481-120504                                Ex19_Fn     aatttctgttcctgttggttttt       120529-10551                                 169 bp
  Ex19_R    gcaaccattccagaaaggaa             120733-120753                                Ex19_Rn     acctctgcccacattgctac          120678-120698                                
  Ex20_F    ttgacgttctcccattttca             121194-121213                                Ex20_Fn     gtgttccacccgtttcattt          121259-121279                                134 bp
  Ex20_R    gaagcatggagatggattcatta          121430-121453                                Ex20_Rn     atcagcccaggttcttgga           121374-121393                                
  Ex21_F    tgtctaggactaacccagctgaa          122719-122742                                Ex21_Fn     tctgtttctttacttgggcaaa        122750-122761                                146 bp
  Ex21_R    tttgagcttgcaagaggaataa           122914-122936                                Ex21_Rn     tgtgatacatttcccatcattg        122874-122896                                
  Ex22_F    tgatggacacacctgtagcaa            126381-126402                                Ex22_Fn     tttcaggaggtagcacatacattt      126431-126455                                250 bp
  Ex22_R    ccaatatctgaaatctgccaaa           126695-126716                                Ex22_Rn     caggcattccctttaaatgac         126659-126680                                
  Ex23_F    gttgagaaacgcacaaagca             159393-159413                                Ex23_Fn     ccatgtatttgtgctaatctctcc      159467-159491                                195 bp
  Ex23_R    catggttgagggaagaagga             159664-159684                                Ex23_Rn     tgggatgacttggcacttac          159642-159661                                
  Ex24_F    tcagtggaagctgctcagta             160784-160803                                Ex24_Fn     actgaggctgaagcatgtcc          160806-160826                                250 bp
  Ex24_R    aggccttccccgattttt               161059-161102                                Ex24_Rn     cccaaccactgctctgagtc          161036-161056                                
  Ex25_F    tgagaagtgctgtggtatggtt           162023-162055                                Ex25_Fn     agggatttgggaatttctgg          162059-162067                                336 bp
  Ex25_R    tgttaagctctaggagaggtggt          162336-162359                                Ex25_Rn     tctttccaaggagaccagctt         162294-162315                                
                                                                                          Ex26-1_Fn   ctgtcagacaaccaataaatgct       184933-184956                                999bp
  Ex26_F    cagtgaccattgtcctgtca             184919-184939                                Ex26-1_Rn   ttgcatcctcctgacttattttt       185909-185932                                
  Ex26_R    tcagtgttcacatttttatttcca         +11/+36[\#](#T000F3){ref-type="table-fn"}    Ex26-2_Fn   caggaggatgcaattgttga          185919-185938                                1048 bp
                                                                                          Ex26-2_Rn   tccagtgtaaaaacacaattctcaa     +33/+56[\#](#T000F3){ref-type="table-fn"}    

numbering according to the GeneBank NG_005114 sequence.

nucleotides upstream the start of the NG_005114 sequence.

nucleotides downstream the NG_005114 sequence.

The nested PCR amplification for all exons was performed in 100 µ l reactions containing a 1:4 dilution of multiplex PCR reaction (25 µ l multiplex reaction in 75 µ l of ddH~2~0), 30 pmol of forward primer and 3 pmol of reverse primer, 0.6 U of polymerase (England Biolabs) to amplify all exons except exons 14 and 26 that required 1 U of polymerase (England Biolabs), and 1X PCR Callida\'s buffer from Callida\'s Genomics. Exon 14 (3.1 kb) and 26 (1.9 kb) required three and two overlapping nested asymmetric PCR, respectively. All PCR reactions were performed using Gene Amp PCR system 9700. PCR reactions were for 45 cycles with an initial denaturation at 96°C and for 3 min, followed by 96°C for 30 sec, annealing at 55°C for 30 sec and extension at 72°C for 1 min. Final extension was at 72°C for 1 min. An aliquot of the PCR product was analyzed on a 1% (w/v) agarose gel to verify size and quality of the PCR product. The single strands are detected with gel-star Nucleic acid Gel stain (Cambrex, Rockland, UK).

Probes {#sec2-4}
------

Amino-modified unlabeled hexamer (6-mer) probes as well as TAMRA and QUASAR labelled pentamers (5-mer) were manufactured and provided by Callida Genomics. HyChip™ slides contain eight replica arrays of a complete set of 4,096 glass-bound 6-mer probes and hundreds of fluorescent and empty marker dots to guide image analysis. A standard universal set of eight probe pools contains a complete set of 1,024 split in two colors: 512 probes are made with TAMRA and 512 with QUASAR. The pools were prepared by mixing 128 specific TAMRA-dye tagged probes and 128 labelled with QUASAR (Callida Genomics, Sunnyvale, CA) divided in 4 separated pools for one strand and four for the other strand. The emission wavelength of TAMRA is 552 nm and for QUASAR is 670 nm.

Target preparation {#sec2-5}
------------------

Prior to hybridization, the PCR nested--asymmetric products were precipitated using isopropanol, creating eight different mixes containing single-stranded DNA of the forward and eight containing the reverse strand. The mixes were performed to optimize the analysis results. We created eight different mixes as follow: exons 1 to 5, exons 6 to 9, exons 10 to17, exons 18 to 25, overlapping fragments 14a, 14b, 14c separately and fragments 26a and 26b in the same mix.

Precipitated DNA was resuspended in 40 µ l of dH~2~O and therefore, the double-stranded PCR template was eliminated by restriction digestion leaving single strands intact. The digestion was performed using Callida\'s pre-made frozen mix in a total volume of 50 µ l with an optimized amount of DNase I (Gibco-BRL, Rockville, MD) at 37°C for 15-20 min followed by inactivation at 95°C for 5 min.

Hybridization {#sec2-6}
-------------

Single-strand DNA mixes (50 µ l) were adjusted to 73 µ l with dH~2~O and added to a frozen aliquot of Callida\'s pre-made ligation mix (47 µ l), containing hybridization buffer (New England Biolabs, Beverly, MA) and an optimized amount of T4 DNA ligase (New England Biolabs, Beverly, MA).

The volume of 120 µ l of DNA-ligase mix (27 µ l) was dispensed into each of the eight labelled 5-mer TAMRA and QUASAR linked probe pools pre-aliquoted in a strip of eight small tubes supplied by Callida. Eight probe pools containing target DNA and ligase were mixed thoroughly and 27 µ l was loaded by pipette onto the HyChip cartridge, where it was drawn by capillary forces into the selected hybridization chamber. Hybridization and ligation occurred in a humidity chamber at room temperature for 60 min.

Slides then were hot-washed (60-65°C) to remove non-ligated labelled probes using Callida\'s detergent (containing washing buffer) for 15 min in an orbital shaker 150 rpm, rinsed four times in dH~2~O and spin-dried at 1500 rpm for 3 min. Slides then were scanned at 20 µ m pixel resolution using a standard array reader GenePix® 4000B setting PMT (532 nm) = 650 and PMT (635 nm) = 750.

Analysis {#sec2-7}
--------

The image analysis and base-calling programs are written in C^++^ programming language. The image analysis program takes advantage of an optimized pattern of fluorescent markers and empty spots on the HyChip™ slide to locate the spotting grid. This allows highly accurate automatic grid and spot detection without the need of any user input (such as clicking a corner spot on a display of the tagged image file format \[TIFF\] image). Robust pattern recognition statistics provide the correct location of spots in imperfect arrays made of shifted subarrays and tolerates a number of missing marker spots. Automated image analysis allows integration of chip scanning with final data analysis. The base-calling software uses an iterative approach to finding the most likely sample sequence, starting from the input reference sequence. For different analyses, it is assumed that the input reference matches the sample sequence more than 90 to 97%. In addition, other limitations (e.g., maximal length of insertions and deletions) are specified. Under these conditions, the algorithm starts by determining the high confidence reference bases, and then testing for various possible mutations to the reference. The program automatically combines hybridization data from two strands or repeated experiments. The following outline lists the main steps of the base-calling process:

1.  Normalize/correct raw spot scores for local variation in array preparation and chip loading.

2.  Create table of normalized scores for all 4,000,000 11-mers by combining all 128 labelled 5-mer probes from each pool with 4,096 6-mer sequences. Groups of 128 11-mers have the same score.

3.  Calculate a base score for each reference position by applying robust statistics on 11 (22 for two strands) overlapping 11-mer intensity scores reading a given base.

4.  Use reference sequence segments that have a strong base score (very likely have no mutation) to remove all full match and mismatch signals expected to be contributed by these sequences to the normalized spot scores.

5.  Generate all single-base changes to the reference (including insertions and deletions) and calculate mutation base intensity scores (the same statistics used as in step 3) and corresponding *P*-values.

6.  Identify candidate mutations with significant *P*-values. Two sequence variants with a high *P*-value would indicate a heterozygote site. For each candidate mutation, modify the reference and calculate the new *P*-values for the region surrounding the potential mutation. Apply a confidence threshold to the new *P*-values and record the accepted mutation.

7.  For sequence sites that have low *P*-value for the reference and all single-base variants, multiple mutations (currently including up to 20 base deletions and up to three base insertions), can be tested following the same general scheme (steps 5 and 6). To detect compound heterozygotes, multiple mutation variants have to be searched across the entire sequence length by a special function.

The implemented base-calling algorithm efficiently uses available data for fast determination (few minutes total for both image analyses of two chips and base-calling of a 3-kb sequence) of most likely sequences present in the analyzed sample using common computers (1 GHz processor, 512 MB of RAM). The speed and accuracy is achieved by combining: 1) iterative sequence assembly starting by first finding non-mutated segments; 2) robust base-calling statistics that use carefully normalized hybridization scores of 11--22 overlapping probes; and, 3) a spot signal deconvolution function based on a database of expected hybridization/ligation efficiency factors for each full-match and mismatch 11-mer. An accurate database of probe behavior is established by statistical analysis of sequencing data obtained on 64 kb of specially prepared DNA. This recently introduced signal deconvolution function is critical for accurate analysis of complex multikilobase samples contributing several single mismatch results per each of 32,768 dot scores representing 128 11-mers each.

Results {#sec1-3}
=======

The new 2-color cSBH is an indirect sequencing method in which overlapping probes of known sequence are hybridized to DNA target molecules. In cSBH, which is represented in a schematic overview in [Figure 1](#F0001){ref-type="fig"}, target DNA from a PCR product is exposed to two universal sets of short probes in the presence of DNA ligase. When both array-bound and solution-phase labelled probe hybridize to target DNA at precisely adjacent complementary positions, they are covalently linked by DNA ligase, creating one long, array-bound labeled probe of known sequence that is complementary to the solution-phase, single-stranded PCR-generated DNA template. A schematic presentation of a cSBH base-calling chromatogram is shown in [Figure 2](#F0002){ref-type="fig"}. The y-axis represents the relative intensity score of the hybridization signal of all overlapping probes at each base. In the presence of strong hybridization signals, the SBH readout appears high, and the reverse is true when there are weak probe hybridization signals. The x-axis represents the position of each base in the sequence analyzed. The computer-called sequence, compared to the known reference sequence used, is represented as the top line of the sequence (in black), and the actual SBH sample sequence readout is directly below (in blue).

![cSBH process. A: Single-stranded nested-PCR template is combined with a ligation mix. B: Mix is dispensed into 8 separate probe pools of 5 mers each containing a complete set of 1,024 split in two colors: 512 TAMRA-labeled and 512 QUASAR-labeled. C: Eight replica arrays of 4096 hexamers each are used to generate a HyChip. A pool mix is loaded onto the array through the loading ports on the slide cover. D: Hybridization at room temperature for 60 min. E: Slides are hot-washed. F: Results are scanned and read on a standard slide scanner. G: Results are scored by image analysis Callida software](IJHG-14-55-g001){#F0001}

![Graphs generated using HyChip™ for three patients. The computer-called sequence is represented on the top line in black; below in blue is the combinatorial sequencing-by-hybridization (cSBH) sequence signal readout on the specific sample tested. At the bottom of the graph are not called by the computer software bases (background). In the panel A the letter D represents an hemizygous deletion of A in Ex12 (sample 2)(DelC aa1194). In the panel B the letter D represents an hemizygous deletion of C in Ex12 (sample 3). In the panel C the letter S represents a T (Sample 64)µ substitution of A](IJHG-14-55-g002){#F0002}

Background bases, which are not called by the computer software, are present at the bottom of all graphs. Use of informative pools of labelled probes allows combinatorial ligation of all labelled and bound probes on one glass slide with only eight universal replica arrays of bound probes. This is the most efficient way to obtain hybridization data for all 4,194,304 11-mers using 32,768 (8 X 4,096) probe spots, an array that can fit only one half of all possible 8-mers. Data of pooled 11-mers are much more informative than data for individual 8-mers because each base is read with 11 instead of eight overlapping probes.

Mutation Detection in Italian Haemophilic A Patients {#sec1-4}
====================================================

A total of 16 clinically diagnosed Italian haemophilic A patients and one obligate carrier previously genotyped and found to have disease-causing mutations in the FVIII gene were included in this study. Patient samples included a range of DNA mutations mapping throughout the FVIII gene. cSBH results are shown in [Table 2](#T0002){ref-type="table"}. We confirmed single-base changes in samples 1, 20, 64, 65, 80, 88, 90, 93, 99. Previous genotyping of samples 2 \[[Figure 2A](#F0002){ref-type="fig"}\], 3 \[[Figure 2B](#F0002){ref-type="fig"}\], 37, and 89 carrying a single-base deletion in exon 14 (fragment b) as well as in sample 6 \[[Figure 2C](#F0002){ref-type="fig"}\] containing a single deletion in exon 12 was confirmed by cSBH. In addition, we found polymorphism in the 3'UTR region (Ex 26, nucleotide 8900 (G→A)) in sample 2, 3, 37, 73, and another polymorphism in the 3'UTR region at nucleotide 8519 A→G in sample 3.

###### 

HA cSBH screen results in 16 patients with known and in 7 patients with unknown mutations

  Sample    Sequencing results   cSBH results                                  
  --------- -------------------- --------------------------------------------- ------------------
  \# 1      Lys1040Stop          Confirmed                                     
  \# 2      Del A Aa 1191-4      Confirmed                                     UTR 3' G→A 8900
  \# 3      Del C Aa 596 novel   Confirmed                                     UTR 3'; A→G 8519
                                                                               UTR 3' G→A 8900
  \# 6      Del A Aa 1191-1194   Confirmed                                     
  \# 20     Lys1270Stop          Confirmed                                     
  \# 37     Del A Aa 1191-1194   Confirmed                                     UTR 3' G→A 8900
  \# 64     Asn235Ile novel      Confirmed                                     
  \# 65     Asn235Ile novel      Confirmed                                     
  \# 73▵    DelTT Aa 2275        Confirmed[\*](#T000F4){ref-type="table-fn"}   UTR 3' G→A 8900
  \# 80     Arg1997Trp           Confirmed                                     
  \# 88     His94Gln             Confirmed                                     
  \# 89     Del A Aa 1441        Confirmed                                     
  \# 90     Pro74Ser novel       Confirmed                                     
  \# 93     Arg1997Trp           Confirmed                                     
  \# 95     Del CT Aa 49 novel   Confirmed[\*](#T000F4){ref-type="table-fn"}   
  \# 99     Arg1997Trp           Confirmed                                     
  \# Cz36   unknown              unknown                                       UTR 3' A→G 8519
                                                                               UTR 3' G→A 8900
  \# P21    unknown              unknown                                       UTR 3' G→A 8900
  \# P25    unknown              Leu1843Thr                                    
  \# R32    unknown              unknown                                       Ser 2182 His
  \# Cz1    unknown              unknown                                       UTR 3' A→G 8519
                                                                               UTR 3' G→A 8900
  \# Cz13   unknown              unknown                                       UTR 3' G→A 8900
  \# Cz34   unknown              unknown                                       UTR 3' G→A 8900

Genotyping was accomplished using a more advanced version of the software

The correct genotyping of a patient (sample 95) and an obligate carrier (sample 73) with 2-bp deletions starting at codons 2275 and 49, respectively, was accomplished using a more advanced version of the software.

We also analyzed samples of 7 haemophilic patients with unknown mutations, who were excluded to carry one of the common HA mutations, inversion of the intron 22 or intron 1. In this setting, we have found a previously undetected missense mutation Leu1843Thr in exon 16 in the sample P25. The mutation was then confirmed by direct gene sequencing. In sample R32 we found another polymorphic change in Ex 23 (Ser 2182 His). In addition, we found a polymorphism in the 3'UTR region (Ex 26, nucleotide 8900 (G→A)) in sample P21, Cz1,Cz13 and Cz34 and Cz36 and another polymorphism in the 3'UTR region at nucleotide 8519 A→G (samples Cz 36 and Cz 1).

Discussion {#sec1-5}
==========

We demonstrated that cSBH, and the related HyChip product, is capable of identifying a range of point mutations located within the FVIII gene making this platform an attractive alternative to standard sequencing methods.

We confirmed known FVIII gene mutations and found that large regions of genomic DNA can be sequenced with excellent readability using only one HyChip array. Because the maximal length of a single PCR product that could be sequenced by the chip is 1.2 kb in size, long exons such as exons 14 and 26 had to be divided in three and two fragments, respectively. The other exons are shorter and could be sequenced in entirety. cSBH sequence data showed 100% accuracy with only 0.2% of bases not called.\[[@CIT10]\] In addition, we demonstrated that the smaller exons 1-25 could be pooled together in groups in a manner allowing their complete sequencing on four different chips, with base readability of 100% and an accuracy of 100%.

The reliability of this technique has been further provided by analyzing a series of HA patients in whom no gene mutation was detected by the first FVIII gene screening, using common strategies (SSCP, DGGE, or dHPLC). This approach was able to identify a new point mutation (Leu1843Thr), which was subsequently confirmed by direct gene sequencing. In the remaining patients, no mutation was found also when the direct gene sequencing approach was applied. Finally, how well this technique does work was provided by the identification of the mutant allele in a heterozygous carrier with one normal factor VIII gene.

Recently, a different approach using a microarray technology has been applied for the detection of FVIII gene mutations.\[[@CIT14]\] As compared with that, the method we used was able to screen all exons using universal probes, rendering this approach reliable for all HA patients carrying a point mutation wherever it is located and chips available for a screening of different HA patients or distinct genes.

cSBH is an efficient, reliable, and easy to use re-sequencing technique that offers an alternative approach for screening of large genes. cSBH allows sequencing of large segments of DNA on only one chip, thereby drastically reducing the time it takes to analyze a specific sequence. Actually the mean time to screen the coding regions of FVIII gene was three days. This period was reduced as compared to the time used in standard methods and comparable to that needed for sequencing analysis. The only equipment required, aside from basic tools (e.g., thermal cyclers, pipettes), is access to a standard array scanner, which makes it a very affordable technique to implement. The required data analysis software, which runs on standard PC computers, will be provided as part of the universal HyChip system and is expected to be economically priced. cSBH is a non-radioactive method and generates sequencing results that can be obtained from genomic DNA within a day. Another major advantage of cSBH are the truly universal HyChip arrays which can be applied to screen any DNA sequence without further probe or oligonucleotide changes, which can be very costly. cSBH offers an efficient and accurate screen for most DNA sequences. The cSBH method is highly reproducible because each base is currently read with 22 overlapped probes (11 per strand). In addition, sample preparation and ligation kits, aliquoted for individual assays, are prepared with all components including enzymes to yield very reproducible biochemical reactions. Furthermore, the base-calling software includes several normalization functions to minimize the influence of experimental variations.\[[@CIT13]\]

The combinatorial ligation of universal probe sets coupled with informative probe pools provides a large number of long (currently 11-mers, potentially 12- to 15-mers in two-probe ligation and 17- to 24-mers in three probe ligation), overlapping probes of predetermined behavior that interrogate each base. Robust statistics take advantage of this redundant dataset to provide accurate base calling in spite of array imperfections (0.5--5.0% of missing dots; high droplet size variation), some impaired probe-target hybridizations due to target--target hybridization, significant experimental noise, and the always-present statistical noise related to probe-pooling and sequence repeats. The main software improvement in the future should address target DNA behavior (e.g., primers/primer dimers, palindromes, direct and inverted repeats, and uneven amounts of target DNA) to aid in a more accurate interpretation of base scores and associated *P*-values. Actually, the presence of short palindromes or repeats may contribute to the number of bases with lower "scores", as seen in sample 2 \[[Figure 2A](#F0002){ref-type="fig"}\]. Furthermore, detection of low-signal AT rich sequences can be improved with optimization of probe concentrations and incorporation of 1,600 AT-rich 7-mers and 8-mers in the arrays, as well as 500 AT-rich 6-mers and 7-mers in the labelled probe pools, which are currently under development.

Universal arrays use probes shorter than gene specific arrays. As a consequence, there is a higher chance to have repeated sequences longer than the length of probes (currently 11-mers in cSBH) occurring in a DNA sample. Such sequences may lead to uncertainty in the sequence assembly. For example, a stretch of 12 As can be perceived as 11, 12, 13, or more As. Also, a mutation in the middle of a repeated 20-mer or any longer segment may not be assigned to the actual copy of the repeat. This situation can be avoided by amplicon design that separates repeats into two sequencing reactions. Short identical repeats several bases in length or longer imperfect repeats, both found in exons or immediate intronic sequences that flank each exon, usually do not confuse the advanced base-calling software.

There are limitations with cSBH analysis: the current software and probe set must be improved to detect DNA alterations within simple repeat regions, which is a problem common to other sequence technologies as well.\[[@CIT10]\]

Another potential complication, which is common to other high resolution methods, including standard Sanger sequencing, is that all sequence changes, polymorphisms and missense changes that do not result in an obvious pathogenic mutation such as a stop codon and are of unknown clinical significance will be detected.\[[@CIT10]\]

In summary, mutation detection for the FVIII gene requires a multimodal approach that can detect the full range of mutations present in this gene. First-stage mutation screening requires a fast, efficient and possibly economical approach to scan the entire gene. cSBH is a technique that is ideally suited. In this study, we showed that cSBH is capable of detecting a broad range of mutations, currently has the capacity to analyze long continuous read lengths of up to 2 kb per chip, and is able to analyze pooled PCR fragments (such as exons 1--25 in this study) on a single universal chip.
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